IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft
Keywords: Cancer stem-like cells; Osteosarcoma; Wnt/β-catenin signaling; Apoptosis; IWR-1; Doxorubicin;